High Resolution Computed Tomography Scoring Systems for Evaluating Interstitial Lung Disease in Systemic Sclerosis PatientsDeborah Assayag1, Sagi Kaduri2, Marie Hudson3, Andrew Hirsch1 and Murray Baron3*
- *Corresponding Author:
- Dr. Murray Baron
Chief of Rheumatology Department
Jewish General Hospital, Suite A 725
3755 Cote St Catherine Rd
Montreal, Quebec, Canada
Tel: +1 514 340 8231
Fax: +1 514 340 7906
E-mail: [email protected]
Received Date: December 07, 2011; Accepted Date: January 24, 2012; Published Date: January 28, 2012
Citation: Assayag D, Kaduri S, Hudson M, Hirsch A, Baron M (2012) High Resolution Computed Tomography Scoring Systems for Evaluating Interstitial Lung Disease in Systemic Sclerosis Patients. Rheumatology S1:003. doi: 10.4172/2161-1149.S1-003
Copyright: © 2012 Assayag D,et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Interstitial lung disease commonly develops in patients with Systemic sclerosis (SSc). High resolution computed tomography (HRCT) has become the gold standard for detection and evaluation of lung involvement in SSc. Several HRCT scoring methods have been described and used to characterize and quantify the disease. This article reviews the different scoring systems and how they have been validated clinically and applied to prognosticate patients, assess disease progression and evaluate response to treatment.